Market Research Logo

Merrimack Pharmaceuticals Inc (MACK) - Financial and Strategic SWOT Analysis Review

Merrimack Pharmaceuticals Inc (MACK) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Merrimack Pharmaceuticals Inc (Merrimack) is a biopharmaceutical company that discovers, develops, and commercializes medicines for the treatment of various types of cancers. The company’s marketed portfolio consists of Onivyde (irinotecan liposome injection) that encases irinotecan (marketed chemotherapy drug) in a liposomal formulation used in the treatment of pancreatic metastatic adenocarcinoma. Its pipeline portfolio includes investigational candidates targeted at the treatment of advanced non-small cell lung cancer (NSCLC), solid tumors, metastatic breast cancer, and heregulin positive breast cancer. The company sells its products through a network of distributors in the US. Merrimack is headquartered in Cambridge, Massachusetts, the US.

Merrimack Pharmaceuticals Inc Key Recent Developments

Aug 14,2017: Merrimack Augments Executive Team with Appointment of Jean Franchi as Chief Financial Officer
Aug 09,2017: Merrimack Reports Second Quarter 2017 Financial Results
Jul 24,2017: Merrimack appoints Thomas Needham as chief business officer
Jun 08,2017: Merrimack Announces Expansion of Senior Management Team with Appointment of Sergio Santillana as Chief Medical Officer and Ellen Forest as Head of Human Resources
May 25,2017: Merrimack Announces Management Change

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company 5
Merrimack Pharmaceuticals Inc - Key Facts 5
Merrimack Pharmaceuticals Inc - Key Employees 6
Merrimack Pharmaceuticals Inc - Key Employee Biographies 7
Merrimack Pharmaceuticals Inc - Major Products and Services 8
Merrimack Pharmaceuticals Inc - History 9
Merrimack Pharmaceuticals Inc - Company Statement 10
Merrimack Pharmaceuticals Inc - Locations And Subsidiaries 13
Head Office 13
Other Locations & Subsidiaries 13
Section 2 – Company Analysis 14
Merrimack Pharmaceuticals Inc - Business Description 14
Merrimack Pharmaceuticals Inc - SWOT Analysis 15
SWOT Analysis - Overview 15
Merrimack Pharmaceuticals Inc - Strengths 15
Merrimack Pharmaceuticals Inc - Weaknesses 16
Merrimack Pharmaceuticals Inc - Opportunities 17
Merrimack Pharmaceuticals Inc - Threats 18
Merrimack Pharmaceuticals Inc - Key Competitors 19
Section 3 – Company Financial Ratios 20
Financial Ratios - Capital Market Ratios 20
Financial Ratios - Annual Ratios 21
Performance Chart 23
Financial Performance 23
Financial Ratios - Interim Ratios 24
Financial Ratios - Ratio Charts 25
Section 4 – Company’s Lifesciences Financial Deals and Alliances 26
Merrimack Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 26
Merrimack Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 27
Merrimack Pharmaceuticals Inc, Recent Deals Summary 28
Section 5 – Company’s Recent Developments 29
Aug 14, 2017: Merrimack Augments Executive Team with Appointment of Jean Franchi as Chief Financial Officer 29
Aug 09, 2017: Merrimack Reports Second Quarter 2017 Financial Results 30
Jun 08, 2017: Merrimack Announces Expansion of Senior Management Team with Appointment of Sergio Santillana as Chief Medical Officer and Ellen Forest as Head of Human Resources 31
May 25, 2017: Merrimack Announces Management Change 32
May 10, 2017: Merrimack Reports First Quarter 2017 Financial Results 33
Apr 17, 2017: Merrimack Pharmaceuticals appoints head of research 35
Mar 01, 2017: Merrimack Reports Fourth Quarter and Full-Year 2016 Financial Results 36
Jan 18, 2017: Merrimack Names Richard Peters, M.D., Ph.D., as President and CEO 38
Nov 09, 2016: Merrimack Reports Third Quarter 2016 Financial Results 39
Oct 03, 2016: Merrimack Announces Major Corporate Restructuring 41
Section 6 – Appendix 42
Methodology 42
Ratio Definitions 42
About GlobalData 46
Contact Us 46
Disclaimer 46
List of Tables
Merrimack Pharmaceuticals Inc, Key Facts 5
Merrimack Pharmaceuticals Inc, Key Employees 6
Merrimack Pharmaceuticals Inc, Key Employee Biographies 7
Merrimack Pharmaceuticals Inc, Major Products and Services 8
Merrimack Pharmaceuticals Inc, History 9
Merrimack Pharmaceuticals Inc, Subsidiaries 13
Merrimack Pharmaceuticals Inc, Key Competitors 19
Merrimack Pharmaceuticals Inc, Ratios based on current share price 20
Merrimack Pharmaceuticals Inc, Annual Ratios 21
Merrimack Pharmaceuticals Inc, Annual Ratios (Cont...1) 22
Merrimack Pharmaceuticals Inc, Interim Ratios 24
Merrimack Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 26
Merrimack Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 27
Merrimack Pharmaceuticals Inc, Recent Deals Summary 28
Currency Codes 42
Capital Market Ratios 42
Equity Ratios 43
Profitability Ratios 43
Cost Ratios 44
Liquidity Ratios 44
Leverage Ratios 45
Efficiency Ratios 45
List of Figures
Merrimack Pharmaceuticals Inc, Performance Chart (2012 - 2016) 23
Merrimack Pharmaceuticals Inc, Ratio Charts 25
Merrimack Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 26
Merrimack Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 27

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report